Completed PHASE4 INTERVENTIONAL NCT00422318

Treatment of Hyperuricemia in Patients With Heart Failure

Hyperuricemia and the Effects of the Uricosuric Agents Benzbromarone in Patients With Chronic Heart Failure

Sponsor: Tottori University Hospital

Updated 4 times since 2017 Last updated: Jan 12, 2007 Started: Jan 31, 2004 Completion: Dec 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00422318, this PHASE4 trial focuses on Heart Failure and Hyperuricemia and remains completed. Sponsored by Tottori University Hospital, it has been updated 4 times since 2004, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jan 2017 — Jan 2021 [monthly]

Completed PHASE4

First recorded

Jan 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Tottori University Hospital

Data source: Tottori University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Yonago, Japan